<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pathophysiology of chronic venous disease</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pathophysiology of chronic venous disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pathophysiology of chronic venous disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Barbara M Mathes, MD, FACP, FAAD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eri Fukaya, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Chronic venous disease is a common medical problem that can result in significant morbidity and mortality. The clinical presentation spans a spectrum from asymptomatic but cosmetically troublesome small ectatic veins (spider veins and reticular veins), to varicosities and edema, to severe skin changes including fibrosing panniculitis, dermatitis, and ulceration. Clinical signs are categorized using the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification (<a class="graphic graphic_table graphicRef52388" href="/z/d/graphic/52388.html" rel="external">table 1</a>). Chronic venous disease is a term that encompasses the spectrum of signs and symptoms (ie, CEAP classifications 1 through 6) whereas chronic venous insufficiency refers to advanced venous disease (ie, CEAP 4 through 6). (See  <a class="medical medical_review" href="/z/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease"</a> and  <a class="medical medical_review" href="/z/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders"</a>.)</p><p>The final common pathway that leads to more severe clinical signs and symptoms is the development of venous hypertension. In most cases, venous hypertension results from obstruction to venous flow, dysfunction of venous valves, and/or failure of the "venous pump." In these situations, flow is directed abnormally from the deep to the superficial system, producing vein dilation, local tissue inflammation fibrosis, and occasionally, ulceration.</p><p>Venous anatomy and physiology, and the pathophysiology of venous hypertension with its clinical consequences are reviewed. Other aspects of chronic venous insufficiency are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">VENOUS ANATOMY</span><span class="headingEndMark"> — </span>The lower extremity venous system is composed of the following three types of veins (<a class="graphic graphic_table graphicRef77469" href="/z/d/graphic/77469.html" rel="external">table 2</a>) (see  <a class="medical medical_review" href="/z/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'Anatomy (The "A" component of CEAP)'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Superficial veins – The superficial veins are a network of subcutaneous veins that are superficial to the deep muscular fascia. The great saphenous and small saphenous veins are called "axial veins," as they course up and down the leg (<a class="graphic graphic_figure graphicRef55019" href="/z/d/graphic/55019.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef52340" href="/z/d/graphic/52340.html" rel="external">figure 2</a>). The "accessory veins" course parallel to the axial veins. "Circumflex veins" run oblique to saphenous canal, and "communicating veins" connect veins in the same compartments. "Tributary veins" are any veins that connect to the axial veins. The rest are considered "simple branch veins."</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Deep veins – The deep veins are located deep to the muscle fascia (<a class="graphic graphic_figure graphicRef75219" href="/z/d/graphic/75219.html" rel="external">figure 3</a>). Deep veins are either within the muscle (ie, intramuscular, such as the gastrocnemius and soleus) or between the muscles (ie, intermuscular); the latter are more important in the development of chronic venous insufficiency [<a href="#rid1">1</a>]. The intermuscular veins, which accompany the lower extremity arteries, include the anterior tibial, posterior tibial, peroneal (fibular), popliteal, and femoral veins. The lower leg intermuscular veins are exposed to high subfascial pressures during calf muscle contraction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Perforator veins – The perforator veins communicate between the deep and superficial venous systems though the fascia. Some sources may refer to thigh perforators veins as Hunter veins, perforators above and below the knee as Dodd and Boyd veins, and calf perforators as Cockett veins. We prefer to use the anatomic description [<a href="#rid2">2</a>]. </p><p></p><p class="headingAnchor" id="H3"><span class="h1">DETERMINANTS OF VENOUS FLOW</span><span class="headingEndMark"> — </span>The venous system is a large-volume, low-pressure, low-velocity, and low-resistance system. For the venous blood to return to the heart, it must overcome hydrostatic pressure induced by gravity and the column of blood from the right atrium to the foot. </p><p>The venous valves and "venous pump" are the two major determinants of this venous flow.</p><p>Venous valves are typically bicuspid. Venous valves direct flow from distal to proximal and from the superficial system to the deep system preventing retrograde flow. An exception to this flow is in the foot, where flow is directed from the deep system to the superficial system via perforators [<a href="#rid3">3</a>]. Venous valves increase in number in direct relation to the hydrostatic pressure; in the distal deep veins, for example, they may occur every 2 centimeters [<a href="#rid1">1</a>].</p><p>The venous pump refers to the pumping effect of calf and intrinsic foot muscles on venous flow. These muscle contractions produce pressure to assist venous return in the lower extremities against gravity by increasing subfascial pressure above intramuscular vein hydrostatic pressure. The pressure differential augments blood flow from the superficial system into the deep venous system, draining the skin and subcutaneous tissues.</p><p>The effectiveness of the pump is dependent upon the presence of adequate muscle contraction and competent venous valves [<a href="#rid4">4</a>]. Competent valves serve two main functions: they prevent the transmission of sudden rises in venous pressure in the superficial veins and capillaries during muscular contraction, and, at the end of muscle contraction, the valves prevent retrograde flow back. When this system is functioning appropriately, the ambulatory venous pressure in the superficial system is maintained between 20 and 30 mmHg.</p><p class="headingAnchor" id="H4"><span class="h1">GENESIS AND CONSEQUENCES OF CHRONIC VENOUS HYPERTENSION</span><span class="headingEndMark"> — </span>In the presence of increased central venous pressure (eg, due to obesity, heart failure, venous compression), venous obstruction, incompetent venous valves, or inadequate muscle contraction, ambulatory venous pressures can reach 60 to 90 mmHg. This level of venous pressure constitutes venous hypertension and is capable of initiating the anatomic, physiologic, and histologic changes associated with chronic venous disease (<a class="graphic graphic_table graphicRef80827" href="/z/d/graphic/80827.html" rel="external">table 3</a>) [<a href="#rid5">5-8</a>]. (See  <a class="medical medical_review" href="/z/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease", section on 'Clinical signs by CEAP category'</a>.)</p><p>Genetic predisposition to chronic venous disease has always been suspected given its high heritability, but no single culprit gene has been identified [<a href="#rid9">9,10</a>]. Many studies have identified candidate genes and gene-related proteins responsible for matrix metalloproteinases, vascular endothelial growth factors, and vascular development. Other genes responsible for abnormal iron metabolism (hemochromatosis C282Y gene mutation) and the development of collagen have also been implicated in the development of chronic venous disease and ulceration [<a href="#rid11">11,12</a>]. Efforts using genome-wide association studies are underway to identify common gene variants associated with varicose veins [<a href="#rid11">11,13</a>]. However, the current understanding is that this not a single gene, but rather a multifactorial disease with epigenetic influences. </p><p class="headingAnchor" id="H5"><span class="h2">Anatomic changes</span><span class="headingEndMark"> — </span>Valvular incompetence is synonymous with venous reflux, in which the vein valves fail to close, causing venous blood to flow in a retrograde direction. This is the most common anatomic abnormality associated with venous hypertension. The resulting increase in venous pressure is transmitted into the superficial venous system causing venous dilation exacerbating venous reflux. The presence of venous obstruction (stenosis, thrombosis) also increases venous pressure which then destroys the valves. For those with venous thrombosis, venous hypertension persists even if the veins are recanalized. When accompanied by clinical symptoms, this defines "post-thrombotic syndrome.” Valvular incompetence can also be associated with fewer valves per unit length, which contributes to higher venous pressures [<a href="#rid14">14</a>].</p><p>This process becomes a vicious cycle. As deep and superficial veins become distended with excess volume, anatomic distortion of the vessel wall produces further valvular incompetence.</p><p>The actual volume of refluxed blood in patients with venous insufficiency may be relatively small. However, when the superficial veins are already maximally distended, small increases in volume produce large increases in pressure [<a href="#rid15">15</a>]. It is the transmission of this excess pressure that leads to inflammatory changes with vessel wall and soft tissue deterioration that is responsible for most of the skin changes characteristic of advanced venous disease. (See  <a class="medical medical_review" href="/z/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease"</a>.) </p><p class="headingAnchor" id="H6"><span class="h2">Physiologic changes</span><span class="headingEndMark"> — </span>Standing is normally associated with reflex constriction of the precapillary arterioles; by diminishing the transmission of arterial pressure to the capillary bed, this response protects the capillary bed from surges in venous hydrostatic pressure when assuming an upright posture. Patients with venous hypertension may lose this reflex; as a result, large increases in venous pressure are transmitted directly to the superficial capillary system [<a href="#rid16">16-18</a>].</p><p>The role of endothelial dysfunction and associated inflammation have been explored as key components in the genesis of chronic venous disease. Shear stress is inversely related to venous pressure. Thus, venous hypertension is associated with a reduction in shear stress. Low shear forces and mechanical stress activate endothelial cells which in turn promotes the release of inflammatory cells into the vein wall and valves promoting local inflammation. Endothelial cells are capable of detecting reductions in shear stress and changes in the microenvironment and respond by releasing nitric oxide, prostacyclin and anti-inflammatory substances [<a href="#rid19">19,20</a>]. However, unchecked local inflammation can lead to endothelial cell dysfunction with reduced production of vasoactive mediators and anti-inflammatory properties [<a href="#rid19">19,20</a>]. This cascade of events ultimately leads to venous wall and valvular damage with abnormal venous wall remodeling characterized by venous dilation and insufficiency [<a href="#rid21">21-23</a>]. </p><p class="headingAnchor" id="H7"><span class="h2">Histologic changes</span><span class="headingEndMark"> — </span>Sustained venous hypertension is associated with characteristic histologic and ultrastructural changes that underlie the cutaneous manifestations of chronic venous disease. </p><p>Venous hypertension is associated with changes in the venous wall, including variation in wall thickness, increases in type 1 collagen, decreases in type III collagen, degradation of extracellular matrix, and reductions in the number of smooth muscle cells [<a href="#rid24">24-26</a>]. These changes weaken the vessel wall and may lead to abnormal venous dilation, including tortuous (eg, telangiectasias, varicose veins) and nontortuous segments [<a href="#rid27">27</a>]. The chronic release of inflammatory mediators is a fundamental cause for the trophic skin changes associated with venous insufficiency. </p><p class="bulletIndent1"><span class="glyph">●</span>Leukocytes accumulate and adhere to the endothelium of small vessels and become activated [<a href="#rid28">28,29</a>]. This microvascular leukocyte-trapping hypothesis is supported by histologic findings of increased numbers of macrophages, T lymphocytes, and mast cells in the tissue of patients with chronic venous hypertension [<a href="#rid30">30,31</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased expression of matrix metalloproteinases and other proteinases by the vessel cells breaks down the vascular extracellular matrix and leads to abnormal vascular permeability and edema. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The presence of proteolytic enzymes in subcutaneous tissues leads to the formation of cutaneous ulcers, which heal poorly and can become chronic [<a href="#rid32">32</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Migration of erythrocytes from the vascular space into tissue, and their subsequent degradation, result in the characteristic brown hyperpigmentation in the gaiter area. The release of ferritin and ferric oxide from the erythrocytes may result in oxidative stress and additional metalloproteinase activation, promoting tissue damage, ulcer formation, and delayed ulcer healing [<a href="#rid33">33</a>].</p><p></p><p>Patients with significant venous insufficiency can develop a severe fibrosing panniculitis of the subcutaneous tissue; the clinical representation of the panniculitis is known as lipodermatosclerosis. (See  <a class="medical medical_review" href="/z/d/html/8198.html" rel="external">"Clinical manifestations of lower extremity chronic venous disease"</a>.)</p><p>Lipodermatosclerosis presents as an area of indurated inflammatory tissue that binds the skin down to the subcutaneous tissue (<a class="graphic graphic_picture graphicRef65447 graphicRef76901 graphicRef73283" href="/z/d/graphic/65447.html" rel="external">picture 1A-C</a>). Lipodermatosclerosis is associated with abnormal, elongated, "glomerular-like" capillaries with increased vascular permeability [<a href="#rid34">34</a>]. Dermal fibrosis may be the result of TGF-β1 fibrogenic cytokine release from activated leukocytes that have migrated out of the abnormally permeable vessels into the tissues. TGT-β1 cytokine increases the production of collagen and subcutaneous fibrosis [<a href="#rid31">31</a>]. Capillaries are virtually absent in areas of fibrotic scars, leading to a condition known as atrophie blanche (<a class="graphic graphic_picture graphicRef112296" href="/z/d/graphic/112296.html" rel="external">picture 2</a>) or livedoid vasculopathy (<a class="graphic graphic_picture graphicRef67105" href="/z/d/graphic/67105.html" rel="external">picture 3</a>) [<a href="#rid35">35</a>]. The lack of blood flow may explain the proclivity for these areas to develop ulcers. (See  <a class="medical medical_review" href="/z/d/html/4684.html" rel="external">"Livedoid vasculopathy"</a>.)</p><p>As with valvular incompetence, worsening lipodermatosclerosis may become part of a vicious cycle. As the fibrosis increases, it may become so extensive and constrictive as to girdle and strangle the lower leg, further impeding lymphatic and venous flow.</p><p class="headingAnchor" id="H3060841"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic venous disease</strong> – Chronic venous disease is a common medical problem that can result in significant morbidity and mortality. The final common pathway that leads to more severe clinical signs and symptoms is the development of venous hypertension, often including the deep venous system. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physiology</strong> – Venous valves direct flow from distal to proximal and from the superficial veins to the deep veins. Blood is directed proximally within the deep venous system by muscular contraction (ie, the "venous pump"). The effectiveness of this pumping action depends on the presence of competent vein valves to prevent retrograde flow. When functioning properly, the ambulatory venous pressure in the superficial system is maintained between 20 and 30 mmHg. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Venous hypertension</strong> – Valvular incompetence is the primary anatomic abnormality associated with venous hypertension, but obstruction (eg, deep vein thrombosis) and failure of the "venous pump" may contribute. Anatomic distortion of the vessel wall from excessive venous pressure exacerbates valvular incompetence. (See <a class="local">'Anatomic changes'</a> above and <a class="local">'Determinants of venous flow'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Histologic changes</strong> – Sustained venous hypertension is associated with histologic and structural changes that lead to increased vascular permeability (edema) and the chronic release of inflammatory mediators that are the fundamental cause of cutaneous hyperpigmentation, trophic skin changes, and ulceration. (See <a class="local">'Physiologic changes'</a> above and <a class="local">'Histologic changes'</a> above.)</p><p></p><p class="headingAnchor" id="H227730416"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledges Patrick C Alguire, MD, FACP, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Tretbar LL. Deep veins. Dermatol Surg 1995; 21:47.</a></li><li><a class="nounderline abstract_t">Caggiati A, Bergan JJ, Gloviczki P, et al. Nomenclature of the veins of the lower limb: extensions, refinements, and clinical application. J Vasc Surg 2005; 41:719.</a></li><li><a class="nounderline abstract_t">Meissner MH. Lower extremity venous anatomy. Semin Intervent Radiol 2005; 22:147.</a></li><li><a class="nounderline abstract_t">Cetin C, Serbest MO, Ercan S, et al. An evaluation of the lower extremity muscle strength of patients with chronic venous insufficiency. Phlebology 2016; 31:203.</a></li><li><a class="nounderline abstract_t">Franzeck UK, Haselbach P, Speiser D, Bollinger A. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI). Yale J Biol Med 1993; 66:37.</a></li><li><a class="nounderline abstract_t">Takase S, Pascarella L, Lerond L, et al. Venous hypertension, inflammation and valve remodeling. Eur J Vasc Endovasc Surg 2004; 28:484.</a></li><li><a class="nounderline abstract_t">Takase S, Pascarella L, Bergan JJ, Schmid-Schönbein GW. Hypertension-induced venous valve remodeling. J Vasc Surg 2004; 39:1329.</a></li><li><a class="nounderline abstract_t">Pascarella L, Penn A, Schmid-Schönbein GW. Venous hypertension and the inflammatory cascade: major manifestations and trigger mechanisms. Angiology 2005; 56 Suppl 1:S3.</a></li><li><a class="nounderline abstract_t">Fiebig A, Krusche P, Wolf A, et al. Heritability of chronic venous disease. Hum Genet 2010; 127:669.</a></li><li><a class="nounderline abstract_t">Grant Y, Onida S, Davies A. Genetics in chronic venous disease. Phlebology 2017; 32:3.</a></li><li><a class="nounderline abstract_t">Ellinghaus E, Ellinghaus D, Krusche P, et al. Genome-wide association analysis for chronic venous disease identifies EFEMP1 and KCNH8 as susceptibility loci. Sci Rep 2017; 7:45652.</a></li><li><a class="nounderline abstract_t">Bharath V, Kahn SR, Lazo-Langner A. Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review. Blood 2014; 124:1242.</a></li><li><a class="nounderline abstract_t">Fukaya E, Flores AM, Lindholm D, et al. Clinical and Genetic Determinants of Varicose Veins. Circulation 2018; 138:2869.</a></li><li><a class="nounderline abstract_t">Sales CM, Rosenthal D, Petrillo KA, et al. The valvular apparatus in venous insufficiency: a problem of quantity? Ann Vasc Surg 1998; 12:153.</a></li><li><a class="nounderline abstract_t">Browse NL. The etiology of venous ulceration. World J Surg 1986; 10:938.</a></li><li><a class="nounderline abstract_t">Stücker M, Schöbe MC, Hoffmann K, Schultz-Ehrenburg U. Cutaneous microcirculation in skin lesions associated with chronic venous insufficiency. Dermatol Surg 1995; 21:877.</a></li><li><a class="nounderline abstract_t">Jünger M, Klyscz T, Hahn M, Rassner G. Disturbed blood flow regulation in venous leg ulcers. Int J Microcirc Clin Exp 1996; 16:259.</a></li><li><a class="nounderline abstract_t">Christopoulos DC, Belcaro G, Nicolaides AN. The hemodynamic effect of venous hypertension in the microcirculation of the lower limb. J Cardiovasc Surg (Torino) 1995; 36:403.</a></li><li><a class="nounderline abstract_t">Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23:168.</a></li><li><a class="nounderline abstract_t">Szmitko PE, Wang CH, Weisel RD, et al. New markers of inflammation and endothelial cell activation: Part I. Circulation 2003; 108:1917.</a></li><li><a class="nounderline abstract_t">Pfisterer L, König G, Hecker M, Korff T. Pathogenesis of varicose veins - lessons from biomechanics. Vasa 2014; 43:88.</a></li><li><a class="nounderline abstract_t">Mansilha A, Sousa J. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. Int J Mol Sci 2018; 19.</a></li><li><a class="nounderline abstract_t">Raffetto JD, Mannello F. Pathophysiology of chronic venous disease. Int Angiol 2014; 33:212.</a></li><li><a class="nounderline abstract_t">Sansilvestri-Morel P, Rupin A, Badier-Commander C, et al. Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res 2001; 38:560.</a></li><li><a class="nounderline abstract_t">Travers JP, Brookes CE, Evans J, et al. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996; 11:230.</a></li><li><a class="nounderline abstract_t">Jacob MP, Badier-Commander C, Fontaine V, et al. Extracellular matrix remodeling in the vascular wall. Pathol Biol (Paris) 2001; 49:326.</a></li><li><a class="nounderline abstract_t">Bergan JJ, Schmid-Schönbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med 2006; 355:488.</a></li><li><a class="nounderline abstract_t">Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J (Clin Res Ed) 1988; 296:1693.</a></li><li><a class="nounderline abstract_t">Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp 1987; 5:311.</a></li><li><a class="nounderline abstract_t">Wilkinson LS, Bunker C, Edwards JC, et al. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg 1993; 17:669.</a></li><li><a class="nounderline abstract_t">Pappas PJ, DeFouw DO, Venezio LM, et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg 1997; 26:784.</a></li><li><a class="nounderline abstract_t">Herouy Y, May AE, Pornschlegel G, et al. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation. J Invest Dermatol 1998; 111:822.</a></li><li><a class="nounderline abstract_t">Wenk J, Foitzik A, Achterberg V, et al. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 2001; 116:833.</a></li><li><a class="nounderline abstract_t">Bates DO, Curry FE. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol 1996; 271:H2520.</a></li><li><a class="nounderline abstract_t">Franzeck UK, Bollinger A, Huch R, Huch A. Transcutaneous oxygen tension and capillary morphologic characteristics and density in patients with chronic venous incompetence. Circulation 1984; 70:806.</a></li></ol></div><div id="topicVersionRevision">Topic 8202 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7600018" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Deep veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15874941" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Nomenclature of the veins of the lower limb: extensions, refinements, and clinical application.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21326687" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Lower extremity venous anatomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25769839" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : An evaluation of the lower extremity muscle strength of patients with chronic venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8256463" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15465369" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Venous hypertension, inflammation and valve remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15192576" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Hypertension-induced venous valve remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16193224" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Venous hypertension and the inflammatory cascade: major manifestations and trigger mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20354728" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Heritability of chronic venous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26786554" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Genetics in chronic venous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28374850" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Genome-wide association analysis for chronic venous disease identifies EFEMP1 and KCNH8 as susceptibility loci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25006132" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30566020" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Clinical and Genetic Determinants of Varicose Veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9514234" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The valvular apparatus in venous insufficiency: a problem of quantity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3798942" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The etiology of venous ulceration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7551745" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Cutaneous microcirculation in skin lesions associated with chronic venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8951524" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Disturbed blood flow regulation in venous leg ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7593156" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The hemodynamic effect of venous hypertension in the microcirculation of the lower limb.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12588755" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Endothelial dysfunction: a marker of atherosclerotic risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14568885" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : New markers of inflammation and endothelial cell activation: Part I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24627315" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Pathogenesis of varicose veins - lessons from biomechanics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29874834" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24755829" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pathophysiology of chronic venous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11740155" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8616659" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11428168" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Extracellular matrix remodeling in the vascular wall.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16885552" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Chronic venous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3135881" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3557818" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Haemoconcentration and accumulation of white cells in the feet during venous stasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8464084" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Leukocytes: their role in the etiopathogenesis of skin damage in venous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9372816" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9804345" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11407968" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8997313" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6488495" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Transcutaneous oxygen tension and capillary morphologic characteristics and density in patients with chronic venous incompetence.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
